Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
暂无分享,去创建一个
John L. Sullivan | Thomas Greenough | Richard T. Ellison | Katherine Luzuriaga | Carol Bova | J. S. Daly | K. K. Lai | Mario Stevenson | Ian Teo | Sunil Shaunak | B. Gazzard | T. Greenough | L. Kostrikis | A. Haase | C. Bova | M. Stevenson | S. Shaunak | M. Nelson | G. Moyle | J. Sullivan | K. Luzuriaga | R. Ellison | Brian Gazzard | Mark Nelson | Graeme Moyle | I. Teo | J. Daly | R. Pat Bucy | Natalia Sharova | N. Sharova | M. Sharkey | Ashley Haase | Claire Veryard | Leondios G. Kostrikis | Mark E. Sharkey | Raul E. Davaro | Sarah H. Cheeseman | Jennifer S. Daly | Brian Mady | Kwan Kew Lai | R. P. Bucy | S. Cheeseman | B. Mady | R. Davaro | C. Veryard | Kwan Kew Lai
[1] Jerome A. Zack,et al. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure , 1990, Cell.
[2] C. A. Macken,et al. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. , 1999, The New England journal of medicine.
[3] E A Emini,et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. , 1997, The New England journal of medicine.
[4] D. Richman,et al. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. , 1997, The Journal of clinical investigation.
[5] P. Brown,et al. Correct integration of retroviral DNA in vitro , 1987, Cell.
[6] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[7] A. Perelson,et al. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy. , 1999, The New England journal of medicine.
[8] J. Mills,et al. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes , 1996, Journal of virology.
[9] Hui Zhang,et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. , 1998, The New England journal of medicine.
[10] B. Levine,et al. Naı̈ve and Memory CD4 T Cells Differ in Their Susceptibilities to Human Immunodeficiency Virus Type 1 Infection following CD28 Costimulation: Implications for Transmission and Pathogenesis , 1998, Journal of Virology.
[11] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[12] M P Dempsey,et al. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.
[13] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[14] M. Stevenson,et al. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products , 1990, Journal of virology.
[15] J. Lisziewicz,et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.
[16] P. Simmonds,et al. Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1 , 1996, The Lancet.
[17] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[18] M. Stevenson,et al. HIV‐1 replication is controlled at the level of T cell activation and proviral integration. , 1990, The EMBO journal.
[19] T. Chun,et al. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[20] Alan S. Perelson,et al. Rapid Clearance of Simian Immunodeficiency Virus Particles from Plasma of Rhesus Macaques , 1999, Journal of Virology.